While antigen-affinity-purified pro-DCD pAbs exacerbated sepsis-induced systemic inflammation and tissue injury, recombinant pro-DCD-C34S and its PEGylation derivatives conferred significant protection when administered at 24 h post-CLP. Here, DCD is linked to Sepsis.